METROPOLITAN LIFE INSURANCE CO/NY - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 114 filers reported holding IRADIMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$20,632
-7.1%
4650.0%0.00%0.0%
Q2 2023$22,199
+21.3%
4650.0%0.00%0.0%
Q1 2023$18,298
+39.1%
4650.0%0.00%0.0%
Q4 2022$13,155
-5.9%
4650.0%0.00%0.0%
Q3 2022$13,978
-11.4%
4650.0%0.00%0.0%
Q2 2022$15,782
-24.3%
4650.0%0.00%0.0%
Q1 2022$20,851
-75.7%
465
-75.0%
0.00%0.0%
Q4 2021$85,9511,8600.00%
Other shareholders
IRADIMED CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 140,752$3,290,0003.17%
RK Capital 222,914$5,212,0001.95%
Nine Ten Capital Management LLC 130,272$3,046,0000.76%
Parkman Healthcare Partners LLC 93,500$2,186,0000.63%
Ranger Investment Management 244,963$5,727,0000.38%
CADENCE CAPITAL MANAGEMENT LLC 107,043$2,503,0000.27%
ALGERT GLOBAL LLC 29,652$693,0000.21%
Mondrian Investment Partners LTD 163,939$3,833,0000.10%
NAVELLIER & ASSOCIATES INC 20,800$486,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 56,811$1,328,0000.04%
View complete list of IRADIMED CORP shareholders